Increased prescription rate of anti‐infective agents after diagnosis of myelodysplastic syndromes

Autor: Johanne Rozema, Mels Hoogendoorn, Iris Potma, Inge tenSeldam, Nic J. G. M. Veeger, Robby E. Kibbelaar, Arjan A. van deLoosdrecht, Eric N. vanRoon, the HemoBase Population Registry Consortium

Publikováno v: eJHaem, Vol 3, Iss 3, Pp 775-784 (2022)

Abstract The a priori risk for infections in patients with myelodysplastic syndromes (MDS) is unknown. This study examines prescription rates of anti‐infective agents in MDS patients before and after diagnosis, in both in‐ and outpatient settings

Externí odkaz: https://doaj.org/article/dce0f2b0252a479c8d785c1494dc8574

Effectiveness of a vitamin D regimen in deficient multiple myeloma patients and its effect on peripheral neuropathy

Autor: Berdien E. Oortgiesen, Marloes Dekens, Ruud Stapel, Abdulrazzaq Alheraky, Pauline de Keizer Dannenberg, Claire Siemes, Frank G. A. Jansman, Robby E. Kibbelaar, Nic J. G. M. Veeger, Mels Hoogendoorn, Eric N. van Roon

Publikováno v: Supportive Care in Cancer, 31(2):138. SPRINGER

Purpose Peripheral neuropathy (PN) is common in multiple myeloma (MM) patients. More insight has been gained concerning the role of vitamin D in preventing PN. However, studies evaluating the effects of vitamin D3 supplementation on PN are lacking. T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f70b2505678b1b667a2d3e989c0e951
https://hdl.handle.net/11370/28ecb70e-868f-4ac6-b855-3bbb862eb21e

Patterns of transfusion burden in an unselected population of patients with myelodysplastic syndromes: A population‐based study

Autor: Harry de Wit, Johanne Rozema, Mels Hoogendoorn, Christiaan L Slim, Robby E. Kibbelaar, Nic J. G. M. Veeger, Eric N. van Roon

Publikováno v: Transfusion, 61(10), 2877-2884. Wiley

BACKGROUND: Ineffective hematopoiesis in patients with myelodysplastic syndromes (MDS) often results in transfusion dependence. The burden of frequent transfusions in the real-world MDS population is largely unknown.STUDY DESIGN AND METHODS: An obser

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec167d0625048c6d33b8da8bd1724076
https://doi.org/10.1111/trf.16631

Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial

Autor: Mels Hoogendoorn, Rineke B L Leys, Dana A. Chitu, Okke de Weerdt, Hanneke C. Kluin-Nelemans, Eva de Jongh, Rien van Marwijk Kooij, Robby E. Kibbelaar, Mars B. van 't Veer, Michel van Gelder, Monique C. Minnema, Marie Josee Kersten, Josée M. Zijlstra, Daphne de Jong, Jeanette K. Doorduijn, M.A. MacKenzie, Tjeerd J. F. Snijders, Pieternella J. Lugtenburg, Lara H Böhmer

Publikováno v: Doorduijn, J K, Zijlstra, J M, Lugtenburg, P J, Kersten, M J, Böhmer, L H, Minnema, M C, MacKenzie, M A, van Marwijk Kooij, R, de Jongh, E, Snijders, T J F, de Weerdt, O, van Gelder, M, Hoogendoorn, M, Leys, R B L, Kibbelaar, R E, de Jong, D, Chitu, D A, Van’t Veer, M B & Kluin-Nelemans, H C 2020, ' Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial ', British Journal of Haematology, vol. 190, no. 3, pp. 385-393 . https://doi.org/10.1111/bjh.16567
British Journal of Haematology, 190(3), 385-393. Wiley
British Journal of Haematology, 190(3), 385-393. Wiley-Blackwell
British Journal of Haematology, 190, 3, pp. 385-393
British Journal of Haematology
British Journal of Haematology, 190, 385-393
British Journal of Haematology, 190(3), 385-393. Wiley-Blackwell Publishing Ltd
British journal of haematology, 190(3), 385-393. Wiley-Blackwell

Contains fulltext : 225496.pdf (Publisher’s version ) (Open Access) Rituximab-containing induction followed by autologous stem cell transplantation (ASCT) is the standard first-line treatment for young mantle cell lymphoma patients. However, most p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48a4ea79a8fe4dc5d93bcc8bbeecbc57
https://doi.org/10.1111/bjh.16567

Fully automated fluorescent in situ hybridization (FISH) staining and digital analysis of HER2 in breast cancer: a validation study.

Autor: Elise M J van der Logt, Deborah A J Kuperus, Jan W van Setten, Marius C van den Heuvel, James E Boers, Ed Schuuring, Robby E Kibbelaar

Publikováno v: PLoS ONE, Vol 10, Iss 4, p e0123201 (2015)

HER2 assessment is routinely used to select patients with invasive breast cancer that might benefit from HER2-targeted therapy. The aim of this study was to validate a fully automated in situ hybridization (ISH) procedure that combines the automated

Externí odkaz: https://doaj.org/article/6857031acd694cfcae604ea7e3c30179